Acadian Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.51M Buy
161,394
+72,542
+82% +$2.04M 0.01% 835
2026
Q1
$2.53M Buy
88,852
+5,969
+7% +$204K ﹤0.01% 894
2025
Q4
$3.27M Sell
82,883
-36,274
-30% -$1.33M 0.01% 770
2025
Q3
$4.19M Sell
119,157
-85,266
-42% -$2.94M 0.01% 697
2025
Q2
$6.69M Buy
204,423
+8,841
+5% +$287K 0.01% 512
2025
Q1
$6.3M Buy
195,582
+188,572
+2,690% +$7M 0.02% 435
2024
Q4
$213K Buy
+7,010
New +$225K ﹤0.01% 1252
2024
Q1
– Sell
-15,235
Closed -$542K – 1566
2023
Q4
$542K Buy
15,235
+6,358
+72% +$236K ﹤0.01% 1013
2023
Q3
$387K Buy
8,877
+1,525
+21% +$74.4K ﹤0.01% 1069
2023
Q2
$362K Buy
+7,352
New +$339K ﹤0.01% 1134
2019
Q3
– Sell
-4,623
Closed -$138K – 1872
2019
Q2
$138K Buy
4,623
+2,321
+101% +$67.8K ﹤0.01% 1314
2019
Q1
$62K Buy
+2,302
New +$69.9K ﹤0.01% 1628

Other funds holding ATRC

Acadian Asset Management's ATRC Position: Q2 2026 in Review

Acadian Asset Management increased its AtriCure (ATRC) stake by 82% in Q2 2026, buying an estimated $2.04M and bringing the position to 161,394 shares worth $4.51M. The position accounts for 0.01% of the portfolio, ranked #835.

Acadian Asset Management first reported a position in ATRC in Q1 2019 and has held it in 12 quarters since. The position peaked at $6.69M in Q2 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Acadian Asset Management held 161,394 shares of AtriCure worth $4.51M as of Q2 2026.
  • Acadian Asset Management bought 72,542 AtriCure shares in Q2 2026, an estimated $2.04M.
  • AtriCure made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #835 holding.
  • Acadian Asset Management first reported a position in AtriCure in Q1 2019 and has held it in 12 quarters since.
  • Acadian Asset Management's AtriCure position peaked at $6.69M in Q2 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.